Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

Share Price is delayed by 15 minutes
Get Live Data
28.80    0.00 (0.00%)
Bid:
27.80
Ask:
29.80
Spread: 2.00 (7.194%)
Market Cap: £76.28m
MIG5 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g Vct5 Share Chart

Interim Management Statement

11 Oct 2013 17:12

RNS Number : 3682Q
Maven Income and Growth VCT 5 PLC
11 October 2013
 



Maven Income and Growth VCT 5 PLC (the Company)

 

Interim Management Statement - quarter ended 31 August 2013

 

This Interim Management Statement, for the quarter ended 31 August 2013, is provided in accordance with Rule 4.3 of the Disclosure and Transparency Rules of the UK Listing Authority and also includes relevant information in respect of the period from 1 September 2013 to the date of issue. This Statement has been prepared solely to provide additional information in order to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules, and should not be relied on by Shareholders, or any other party, for any other purpose.

 

1.

Financial highlights

 

· Net asset value (NAV)1 of 34.93p per share at 31 August 2013, after payment of the interim dividend, compared to 34.67p per share at 31 May 2013;

· NAV total return2 of 60.23p at 31 August 2013, compared to 59.32p at 31 May 2013; and

· Interim dividend of 0.65p per share in respect of the year ending 30 November 2013, paid on 30 August 2013.

 

1The NAV is unaudited and reflects the closing bid price of quoted securities at 31 August 2013. Unlisted companies are normally valued on a six-monthly basis and the NAV incorporates the Directors' valuation of unlisted investments as at 31 May 2013, adjusted for subsequent events where appropriate.

2NAV total return is the sum of NAV per share and dividends paid per share since launch.

 

2.

Investments and disposals

 

During the quarter ended 31 August 2013, a net amount of £2,042,422 was invested in seven unlisted companies. In the same period, proceeds of £2,699,826 were realised from the sale of short-dated UK treasury bills; and the full or partial disposals of three AIM quoted investments generated aggregate proceeds of £194,874 against a total cost of £79,625.

 

3.

Recent developments

 

Between 1 September 2013 and the date of this Statement, £1,798,697 was invested in short-dated UK treasury bills; and the full or partial disposals of eleven AIM quoted investments generated proceeds of £ 1,400,754 against a cost of £ 1,023,854.

 

4.

NAV disclosure and Offer for Subscription

 

The NAV as at close of business on 10 October 2013 was 36.37p per share and reflects the closing bid price of quoted securities at that date. Unlisted companies are normally valued on a six-monthly basis and the NAV incorporates the Directors' valuation of unlisted investments as at 31 May 2013, adjusted for subsequent events where appropriate.

 

As announced on 25 September 2013, the Company intends to raise up to £3 million by way of a joint Offer for Subscription alongside the other venture capital trusts managed by Maven Capital Partners UK LLP. It is intended that the NAV per share as at 10 October 2013 will be used as the basis for the subscription price for the new shares, subject to there being no material movement in the underlying net asset value. The NAV per share of the Company has, to date, been released on a daily basis. With immediate effect it is intended that, other than in exceptional circumstances, the Company will release NAV figures on a quarterly basis through annual and interim results announcements and interim management statements.

 

Other than as described above, and changes in the value of investments quoted on regulated markets, the Board is not aware of any material events during the period from 1 June 2013 to 31 August 2013, or in the period from 1 September 2013 to the date of this announcement, which would have had a material impact on the financial position of the Company.

 

Issued on behalf of the Board

 

Maven Capital Partners UK LLP

Secretary

 

11 October 2013

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSQFLFFXBFFFBF
Date   Source Headline
10th Sep 20219:57 amRNSDirector/PDMR Shareholding
10th Sep 20219:31 amRNSIssue of Equity
7th Sep 20213:09 pmRNSStatement re Dividend Investment Scheme
10th Aug 20214:31 pmRNSHalf-year Report
5th Aug 20219:17 amRNSStatement re NAV and Interim Dividend
7th May 20213:54 pmRNSTransaction in Own Shares
7th May 20212:06 pmRNSDirector/PDMR Shareholding
7th May 20212:06 pmRNSDirector/PDMR Shareholding
7th May 20212:03 pmRNSIssue of Equity
5th May 202112:56 pmRNSTransaction in Own Shares
4th May 20214:01 pmRNSStatement re Dividend Investment Scheme
4th May 20213:54 pmRNSDirector/PDMR Shareholding
4th May 20213:25 pmRNSIssue of Equity
27th Apr 20211:46 pmRNSNet Asset Value(s)
27th Apr 20211:17 pmRNSResult of AGM
6th Apr 20217:00 amRNSIssue of Equity
1st Apr 202110:33 amRNSStatement re Offer for Subscription
23rd Mar 20213:41 pmRNSPublication of Suppl.Prospcts
15th Mar 20213:37 pmRNSAnnual Financial Report
3rd Mar 20213:05 pmRNSHolding(s) in Company
3rd Mar 20217:05 amRNSDirector/PDMR Shareholding
3rd Mar 20217:05 amRNSDirector/PDMR Shareholding
3rd Mar 20217:00 amRNSIssue of Equity
24th Feb 20214:41 pmRNSTransaction in Own Shares
16th Feb 20217:00 amRNSNet Asset Value and Proposed Final Dividend
8th Feb 20213:59 pmRNSStatement re Offer for Subscription
28th Jan 20214:40 pmRNSStatement re Offer for Subscription
30th Nov 20204:47 pmRNSTransaction in Own Shares
27th Nov 202010:45 amRNSResult of General Meeting
23rd Nov 20205:03 pmRNSTransaction in Own Shares
16th Nov 20204:49 pmRNSTransaction in Own Shares
26th Oct 20207:00 amRNSPublication of a Prospectus
16th Oct 202010:15 amRNSNet Asset Value(s)
28th Aug 202011:27 amRNSDirector/PDMR Shareholding
28th Aug 202010:31 amRNSIssue of Equity
26th Aug 20205:24 pmRNSTransaction in Own Shares
21st Aug 20204:11 pmRNSStatement re NAV and DIS
31st Jul 20207:00 amRNSHolding(s) in Company
29th Jul 20205:11 pmRNSTransaction in Own Shares
29th Jul 202010:55 amRNSHalf-year Report
22nd Jul 20202:25 pmRNSStatement re Intended Joint Offersfor Subscription
16th Jul 20202:38 pmRNSStatement re NAV and Interim Dividend
29th Jun 20202:44 pmRNSDirector Declaration
14th May 20204:47 pmRNSTransaction in Own Shares
29th Apr 20204:36 pmRNSTransaction in Own Shares
28th Apr 202012:12 pmRNSResult of AGM
26th Mar 20205:25 pmRNSUpdate on Net Asset Value
26th Mar 20205:01 pmRNSSuspension of Dividend Investment Scheme (DIS)
19th Mar 20204:30 pmRNSAGM Update – Notification of Change of Venue
11th Mar 20205:23 pmRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.